Pharmaco - Press Releases

Date	Title	Company
28-Sep-2021	Relief Reports that its U.S. Collaboration Partner has Announced Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMITM (RLF-100TM/aviptadil)	RELIEF THERAPEUTICS Holding AG
27-Sep-2021	Formycon Reports on Virtual Annual General Meeting 2021	Formycon AG
27-Sep-2021	Nantes University Hospital Doses First Patients with Eckert & Ziegler's Novel Ga-68 Imaging Agent PENTIXAFOR	Eckert & Ziegler Strahlen- und Medizintechnik AG
27-Sep-2021	IGEA Pharma N.V.: IGEA HAS BEEN GRANTED THE LISTING OF THE NEW SHARES FROM SIX EXCHANGE REGULATION.	IGEA Pharma N.V.
27-Sep-2021	Bayer Middle East announces partnership with the United Nations Population Fund Egypt, to support the Ministry of Health and Population’s ‘Your Right to Plan’ campaign in Egypt on World Contraception Day	Bayer Middle East
27-Sep-2021	New research presented at IDWeek 2021 reinforces Sanofi’s robust vaccines pipeline and commitment to advancing public health protection	Sanofi
27-Sep-2021	Takeda Receives Approval to Manufacture and Market Alofisel®▼ (darvadstrocel) in Japan for Treatment of Complex Perianal Fistulas in Patients with Non-active or Mildly Active Luminal Crohn’s Disease	Takeda
27-Sep-2021	Fully Human Anti-TNFα Monoclonal Antibody HUMIRA® Obtains Additional Approval for High-Dose Regimen of Ulcerative Colitis in Adult Patients and for New Regimen in Pediatric Patients	Eisai
27-Sep-2021	aap Implantate AG resolves on capital increase with subscription rights to finance sales growth and start of human clinical study for antibacterial silver coating technology	aap Implantate AG
27-Sep-2021	Polyphor publishes invitation to Extraordinary General Meeting and announces financial results for the first half 2021	Polyphor AG
27-Sep-2021	Evolva issued 40’000’000 shares out of authorized capital	Evolva Holding SA
24-Sep-2021	Kizoo Portfolio Company Underdog Closes $10M Financing Round	Underdog Pharmaceuticals
24-Sep-2021	Sanofi celebrates 30th Anniversary of Sanofi Genzyme’s Humanitarian Program	Sanofi
24-Sep-2021	Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster	Pfizer and BioNTech
24-Sep-2021	Lynparza in combination with abiraterone significantly delayed disease progression in all-comers in PROpel Phase III trial in 1st-line metastatic castration-resistant prostate cancer	AstraZeneca
24-Sep-2021	Roche presents new data at World Muscle Society (WMS) 2021 highlighting new advances for people living with rare neuromuscular disorders	Roche
24-Sep-2021	Baxter Announces U.S. Approval and Launch of Ready-To-Use Cardiovascular Medicine Norepinephrine in Premix Formulation	Baxter
24-Sep-2021	Relief Reports Half-Year 2021 Results and Provides Corporate Update	RELIEF THERAPEUTICS Holding AG
23-Sep-2021	Abivax presents first-half 2021 financial results and operations update	ABIVAX
23-Sep-2021	First Net Zero Mass Spectrometer Launched to Support Greener Future	Thermo Fisher Scientific